Neuromodulation Medicine Fellowship
The University of Minnesota Medical School recently established an innovative one-year multidisciplinary Subspecialty Fellowship program in Neuromodulation Medicine. Participating Departments are Neurology, Neurosurgery, Psychiatry and Rehabilitation Medicine. The program is non-ACGME accredited, and is funded through the Discoveries and treatments for Brain Conditions area of the Minnesota Discovery and InnoVation Economy (MnDRIVE) initiative.
The main goal of the fellowship is to provide the opportunity to develop the expertise necessary to evaluate and manage patients with neuromodulation-amenable disorders using specialized procedures and techniques. It is the intent of the University of Minnesota Neuromodulation Medicine training program to develop neurology, neurosurgery, psychiatry and rehabilitation medicine specialists into competent, independent neuromodulation subspecialists. Fellows will receive extensive training in the use of neuromodulation for clinical evaluation treatment and rehabilitation across a wide range for modalities, with emphasis on the specialty of the trainee. Fellows are expected to rotate in all disciplines and be involved with research.
Applicants must have graduated from an ACGME accredited training program (or equivalent) in Neurology, Neurosurgery, Psychiatry or Rehabilitation Medicine, and be board certified or board certification eligible.
Acceptance into the program will be made by the primary and specialty program directors and faculty based on the individual's qualifications, including curriculum vitae and letters of recommendations from the training program from which the applicant has graduated. Preference will be given to individuals with an interest in pursuing a career in academic medicine.
The program is administered through the Department of Psychiatry & Behavioral Sciences. Applications are currently being accepted for the 2023-2024 and 2024-2025 academic year. The deadline to apply for the 2023-2024 academic year is Friday, November 25.
Application requirements for Neuromodulation Medicine Fellowship:
- Formal letter expressing personal interest in the Neuromodulation Medicine Fellowship.
- Current Curriculum Vitae
- Three letters of reference from the training program from which applicant will or has graduated
- Completion of the Application
All application materials and inquiries for the Neuromodulation Medicine Fellowship:
Applications are currently being accepted for the 2023-2024 and 2024-2025 academic year. The deadline to apply for the 2023-2024 academic year is Friday, November 25.
Interventional Psychiatry - UMMC Riverside
Electroconvulsive therapy (ECT) with Dr. Ziad Nahas.
Interventional Psychiatry - St. Louis Park
Treatment resistant depression, TMS and ketamine with Dr. Ziad Nahas.
Research - Dr. Alik Widge
Attend laboratory meetings. Through those meetings, learn about ongoing research in neurostimulation and the considerations in designing such research, both in humans and in animal models. Observe research procedures across multiple studies to understand the interaction between neuromodulation medicine and next-generation treatment development. Meet with individual faculty preceptors and learn about their research programs, including focused projects that might be conducted (e;g., secondary data analysis, work with our patient registries). With the concurrence of a faculty mentor (or designate, e.g. a staff scientist in their lab), design and carry out a supervised scholarly project. This may not require data analysis – preparation of a qualitative review or book chapter is also a scholarly endeavor. The expected output of this yearlong experience is a written scholarly product, which may be an article/chapter as just noted, or might be a poster at a professional meeting such as the annual Minnesota Neuromodulation Symposium.
Woodwinds DBS - Woodbury
- Deep Brain Stimulation (DBS) programming for treatment of Essential Tremor (ET), motor symptoms of Parkinson disease (PD) and dystonia with Dr. Kristine Domingo.
- Attend and present patients at the Movement Disorders Division DBS Consensus.